SEC Form 4 · accession 0001179110-18-010636
RIGEL PHARMACEUTICALS INC · RIGL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nelson Cabatuan
Officer — Principal Accounting Officer
Period of report
Aug 14, 2018
Accepted (ET)
Aug 16, 2018 · 6:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001034842
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $2.76 | Aug 14, 2018 | A | 20,000 | A | — | Aug 14, 2028 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1The shares of common stock subject to the option vest in equal monthly installments over forty-eight (48) months from the vesting commencement date of August 14, 2018.